Heart in Diabetes 2019
https://www.heartindiabetes.com
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
https://www.heartindiabetes.com
https://www.prnewswire.com/news-releases/veroscience-presents-new-pipeline-data-for-metabolic-disease-therapies-at-2019-american-diabetes-association-meeting-300864258.html
https://www.professional.diabetes.org/scientific-sessions
https://am.aace.com/index.asp
https://www.endocrine.org/
https://www.heartindiabetes.com
http://professional.diabetes.org/meeting/scientific-sessions/78th-scientific-sessions
http://professional.diabetes.org/meeting/scientific-sessions/77th-scientific-sessions
http://www.pri-med.com/medical-conferences/2017/annual-conference-west.aspx
http://aace2017.org/index.html